cardiology Flashcards
soft first heart sound heard with
- mitral regurgitation
- long PR interval
- LBBB
- aortic stenosis, aortic regurg
- immobile mitral valve
loud first heart sound heard with
- mitral stenosis
- short PR interval ie: WPW
- tachycardia
- thyrotoxicosis
second heart sound splits with
inspiration
wide splitting second heart sound heard with
- MR, VSD
- RBBB
- pulm artery hypertension
fixed second heart sound heard with
**ASD-only thing causing fixed!!
S3 heard in
- normal in children
- mitral regurg
- tricuspid regurg
- CHF
S4 heard in
- hypertension
- aortic stenosis
- hypertrophic cardiomyopathy
- angina, myocardial infaction
- ACUTE mitral regurg-NOT chronic
heart sound-clicks heard in
- early systolic-aortic stenosis, pulmonary stenosis
* mid systolic- MVP
opening snap heard in*
- mitral stenosis, tricuspid stenosis
* shorter the interval, more severe the stenosis is
pericardial friction rub heard with
pericarditis
pericardial knock
constrictive pericarditis
palpable heave at heart apex
LVH
Kussmaul sign
incease of JVP on inspiration
*see w constrictive pericarditis , RV infarct
JVP >4cm above the sternal angle or >9cm above the right atrium is
considered abnormal
Giant a wave on Jugular venous pulse tracing (cannon a wave)
produced when the atrium contracts against resistance as in tricuspid stenosis
holosystolic heart murmur heard with
mitral regurg
tricuspid regurg
VSD
midsystolic heart murmur heard with
aortic stenosis
pulmonary stenosis
functional murmur
continuous heart murmur is heard with
PDA
increase in heart murmur with standing and valsalva
MVP
hypertrophic cardiomyopathy
(all other maneuvers assoc w all other murmurs)
opening snap and loud P2
mitral stenosis
pulsus tardus pulse pattern assoc with
aortic stenosis
pulsus bisferiens pulse pattern assoc w
aortic regurg
pulsus alternans pulse pattern assoc w
cardiac tamponade
severe LV failure
paradoxical pulse
- drop in systolic BP>10mm on inspiration
* see in: cardiac tamponade, airway obstruction, SVC obstruction
30 yr old who is 3 months pregnant has a grade 2 early systolic murmur over LSB. the murmur disappears on standing
innocent murmur of pregnancy, no work up if grade 2 or less
40 y/o male has a JVP of 3 cm above the sternal angle and increases to 8cm after applying pressure on the liver
- called hepatojugular reflex
* means impending or active CHF
30 y/o has a midsystolic click & late systolic murmur, the murmur increases on standing & valsalva
*MVP
wide splitting S2 , soft P2, early systolic click, cannon wave, midsystolic crescendo-decrescendo murmur over LSB
pulmonary stenosis
murmur that is machinery and continuous means
PDA
holosystolic murmur that increases with inspiration
tricuspid regurg
if no change w inspiration-VSD
most common cause of mitral regurg
MVP
clinical features of MVP
- palpitations, cp, supraventricular & ventricular arhythmias
- midsystolic click and late systolic murmur
- stand and valsalva cause click and murmur to occur early
complications of MVP
LV failure
systemic emboli from platelet fibrin deposits on valves
sudden death-very rare
tx of MVP
- B blocker-palpitations, CP, anxiety or fatigue
- ASA-unexplained TIA w sinus rhythm & no atrial thrombus
- warfarin-recur TIA despite ASA or hx of stroke
- surgery-severe MR
indications for ECHO to eval a heart murmur
- presence of cardiac symptoms
- systolic murmur >/= grade 3
- continuous murmur
- any diastolic murmur
- new murmur from previous exam
Grades of murmurs
1-very faint, may not hear in all positions
2- quiet, hear immediately after placing a stethoscope
3-moderately loud
4-loud, with a palpable thrill
5-very loud, thrill, may be heard w stethoscope PARTLY OFF chest
6-as above but may be heard w scope ENTIRELY off the chest
PCWP-pulmonary capillary wedge pressure
measures LA pressure from R side of heart by blocking R side w balloon
*normal is 6-12mm Hg
PCWP is normal with
pulmonary artery hypertension PAH
COPD
pulmonary embolism
PCWP increased with these conditions
mitral stenosis
LV failure
hemodynamic monitoring in septic patient or in anaphylaxis will see SVR
decreased
all other conditions increase SVR
Right ventricular infarct clinical features
- one third of patients with INFERIOR MI
- ST elevation : V3R-V6R
- low BP
- increased JVP
- positive Kussmaul sign
- clear lungs
RV infarct treatment
- volume loading if hypotension persists
- inotropic support w dopamine or dobutamine
- NO nitrates or diuretics
- all other tx MI-thrombolytic, PCI as indicated
clinical features of constrictive pericarditis
rigid pericardium> impaired cardiac filling
- gradual onset dyspnea
- pedal edema
- ascites hepatomegaly, incr JVP
- kussmal sign
causes of constrictive pericarditis
- TB, viral
- prior cardiac surgery,radiation
- collagen vasc disorders
- uremia
- malignancy
diagnosis of constrictive pericarditis
- EKG: low voltage
- CXR: may see pericardial calcification
- ECHO,CT/MRI-pericardial thickening
- heart cath-**see equalization of diastolic pressures in ALL chambers and ventricular pressure tracing show dip & plateau “square root sign”
- TX: surgical stripping of pericardium
clinical features of cardiac tamponade, rapid onset of:
- dyspnea
- hypotension
- tachycardia
- paradoxical pulse
- distant heart sounds, incr JVP
causes of cardiac tamponade
- previous pericarditis
* cardiac trauma of any kind- including perforation during cath or pacer placement
DX cardiac tamponade
- EKG: low voltage, ELECTRICAL ALTERNANS w large effusion
- CXR: enlarged heart
- ECHO: see effusion and RA & RV collapse in diastole
- CATH: equalizaion of diastolic pressures in all 4 chambers
TX cardiac tamponade
- pericardiocentesis
* IV volume expansion
Acute MI caused by
- plaque rupture of pre-existing 30-50% stenosis of the artery>mural thrombi>complete occlusion>MI
- *slowly developing high grade stenosis DOES NOT precipitate acute MI
Inferior coronary ischemia
*II,III,aVF
right coronary artery
anteroseptal coronary ischemia
*V2-V4
LAD
anterior coronary ischemia
V3-V5
LAD
lateral coronary ischemia
V5-V6
LAD or circumflex
posterior coronary ischemia
V1,V2 (reciprocal)
right coronary artery
right ventricular coronary ischemia
V3R, V4R
right coronary artery
exercise stress-bruce protocol
*5 stages- 3 minutes each w slope and speed changes
POSITIVE: >/= 1mm ST depression lasts >/= .08seconds flat or downsloping
stress testing-poor prognostic factors:
- > 2mm ST depression at 5min post exercise
- fall in systolic BP >10-15 mm
- global changes -change in anterior & inferior leads
- ventricular ectopic beats
- ST segment elevation
exercise stress testing- absolute contraindications
- severe aortic stenosis
- recent MI
- unstable angina-within 48hours
- uncontrolled arrhythmia
- decompensated heart failure
- acute aortic dissection
- acute pulmonary embolism
When to stop the stress test
- achieved predicted HR (200-age)
- severe angina
- development of >2mm ST depression
indications for radionuclide myocardial perfusion imaging
thallium, sestamibi, tetrafosmin (myoview)
- WPW syndrome
- digitalis effect
- baseline ST depression >1mm
- LVH w strain
- prior CABG or coronary interventions
pharmacologic stress test
*for those that cant exercise-COPD, arthritis, PAD
adenosine or dipyridamole stress test
best for: LBBB, pacemaker
Contraindications: COPD, asthma, elevated BP, sick sinus, high grade heart block
dobutamine stress test
best for :COPD, asthma
Medical tx of angina
- *beta blockers-BEST initial therapy
- calcium channel blocker-best if Beta B contraindicated
- nitrates - 14 hour dose free interval
- ranolazine-if remain symptomatic on above therapy
- vasoprotective therapy-all w angina:
- aspirin, clopidogrel if aspirin allergy
- statin-LDL goal<35%
- stop smoking, wt control, exercise
- omega 3 fatty acid, diet rich fruit, veg,extra virgin olive oil, nuts
Indications for coronary angiography
- disabling angina symptoms
- high risk criteria on noninvasive testing
- survivor of sudden cardiac death or serious vent. arrhythmia
- symptoms/signs of CHF
- pt who continue to have ischemia in the early postMI or unstable angina setting
PCI-percutaneous coronary intervention
- *does NOT reduce future cardiovascular events
- reduces frequency and severity of angina
- does NOT improve survival
*reserved for those who remain symptomatic despite optimal medical tx except for pt w significant silent ischemia on stress testing
aspirin + clopidogrel
should be given together for a minimum of 1 year after drug eluding stent and 1 month after bare metal stent
*ASA used indefinately after stent placement
indications for CABG
- left main disease >/= 50%
- 3 vessel disease >/= 70% (survival benefit is greatest if EF<50%)
- multivessel CAD in diabetes **CABG is superior to PCI , CABG reduces the rates of death and MI with higher rates of stroke
ACS-acute coronary syndrome
- STEMI
- NSTEMI
- unstable angina
STEMI
ST elevation
elevated troponin & CK-MB
NSTEMI
ST segmant depression and T wave inversion
elevated troponin & CK-MB
unstable angina
nonspecific EKG changes
normal troponin and CK-MB
duration of clopidogrel therapy
- minimum of one year with:
- no stent
- bare or drug eluding stent
- CABG
- ASA indefinately
Unstable angina
*angina at rest or minimal exertion, usually lasts >10 minutes
- new onset of severe angina within the prior 4-6 weeks
- recent increase in frequency and/or intensity of chronic angina
**if enzymes are +: NSTEMI
Unstable angina or NSTEMI
- HIGH RISK: coronary angiography indicated in 24-48 hours
- presence of any of these risk factors:
- new ST segment depression
- elevated troponin or CK MB
- recurrent angina at rest or low level activity despite rx
- strong + stress test
- CHF symptoms or EF/= 3
TIMI risk score (>/= 3 is high risk)
- age 65 or greater
- 3 or more traditional CAD risk factors
- ASA use in past week
- documented CAD w 50%or greater stenosis
- severe angina, 2 or more episodes within 24 hours
- ST segmant deviation of .05mV or more\
- elevated cardiac enzymes
Treatment of unstable angina or NSTEMI
- ASA
- clopidogrel or prasugrel or tricagrelor
- beta blocker
- nitrates
- LMWH or UFH or fondaparinux
- statin
- if HIGH risk: coronary angiography to determine other options
GPI -> GP IIb/IIIa inhibitors
*abciximab, eptifibatide, tirofiban
not given before cardiac cath , decision to give these drugs or not is made at PCI
Indications for hospitalization in chest pain:
- ST elevation on EKG
- ST depression or T wave inversion on EKG
- CK MB
+ troponin I or T
- Hx suggestive of unstable angina w normal EKG
- concurrent CHF, hypotension, or transient mitral regurgitatin
Tx STEMI
- O2, MS, nitrates, beta blocker, asa and plavix
- Heparin/LMWH 48 hours
- ACE-start when the pt is Hemodynamically STABLE
- high dose statin-atorvastatin 80mg
- cath lab available-Primary PCI is superior to lysis **within 90 minutes “door to balloon”time of initial medicl contact
- cath NOT available: fibrinolytic within 30 minutes or consider transfer to PCI able hospital
Transfer to primary PCI is favored if:
- door to balloon time < 90 minutes
- pt presenting >3 hours after onset of symptoms
- cardiogenic shock
- high risk of intracranial hemorrhage or bleeding
Indications for fibrinolytic therapy
- acute CP typical of MI
- EKG criteria of STEMI
- ST elevation 1mm or more in 2 or more leads in inferior or lateral
- ST elevation 2mm or more in at least 2 contiguous anterior leads
- new LBBB
Use fibrinolytic therapy
*12 hours (PCI for those with ongoing ischemia or those at high risk)
fibrinolytic agents
- tPA (alteplase), reteplase, tenecteplase, streptokinase(No heparin w streptokinase)
- give IV heparin for 48 hours if the first 3 above agents are used, maintain PTT 1.5 to 2 X control (50-70)
benefits of fibrinolytic therapy
- decrease infarct size
- improvement in LV function
- decrease mortality
bleeding complications of fibrinolytic therapy
- intracerebral bleeding 1% (if occurs mortality 50-65%)
* risk factors:older age, lower body weight, female sex, prior stroke, systolic BP>160
Absolute contraindications to fibrinolysis
- any prior intracranial hemorrhage
- known structural cerebral vasc lesion-AV malformation
- ischemic CVA within 3 months
- known malignant intracranial neoplasm
- suspected acute aortic dissection
- active bleeding or bleeding diathesis (EXCLUDES menses)
- significant closed head injury or facial trauma within 3 months
Relative contraindications fibrinolysis
- BP >180/110 on presentation
- prior ischemic stroke >3 months
- prolonged CPR>10min
- major surgery within 3 weeks
- internal bleeding within 2-4 weeks
- pregnancy
- non compressible vascular punctures
- active PUD
- current use of anticoagulants
- for streptokinase: prior exposure >5 days ago or prior allergic rxn
Feature that suggest successful reperfusion after fibrinolysis
- complete resolution of CP
- improvement of ST elevation >50% in EKG after 60 minutes
- development of reperfusion arrhythmias:
- accelerated idioventricular rhythm
- PVCs
Indications for coronary angiography after fibrinolytic therapy
- failure of reperfusion (persistent CP and ST elevation >90 min)
- coronary artery reocclusion (re elevation of ST or recur CP)
- recurrent angina in the early hospital course
- positive stress test before discharge
Indications of full dose anticoagulation after STEMI
**UFH or LMWH followed by warfarin for 3-6 months
- severe CHF
- ventricular thrombus on ECHO
- large dyskinetic region on anterior wall MI
Indicatons for PCI (angioplasty/stent) in acute STEMI:
- can be done within 90 minutes
- contraindications to fibrinolytic therapy
- cardiogenic shock: SBP20, oliguria
- hypotension and hemodynamic instability
- pt presents >12 hr after onset of CP w cont CP or ST elevation
- high risk pt tx initially w fibrinolytics in non PCI hosp transfer for diagnostic cath as soon as possible
- non high risk pt transfer if ischemic symptoms persist
no benefit of late PCI (after one week) of
occluded infarct related artery
treatments that IMPROVE SURVIVAL after MI:
- fibrinolytic tx or PCI in STEMI
- ASA,Plavix
- beta blockers
- ACE inhibitors-even if normal LV function and normal BP
- anti lipid therapy
- smoking cessation
- exercise
- ICD insertion if EF 30% or less AFTER 30 days of MI
- eplerenone in EF5)
Cardiovascular complications of Cocaine
- myocardial ischemia and infarction
- LVH
- systolic dysfunction & dilated cardiomyopathy
- reversible profound myocardial depression after binge use
- cardiac dysrhythmias
First line tx of cocaine induced MI or ischemia
- oxygen
- nitroglycerine
- benzodiazepine
second line therapy in cocaine induce MI or ischemia
- verapamil
- phentolamine
- coronary angiography if conservative tx fails
agents to AVOID in cocaine induced MI or ischemia
- **Beta blockers ***increase vasoconstriction induced by cocaine!
- thrombolytics not routinely used
HOPE trial
- Ramipril (ACE)
- reduces risk of MI, CVA,death from CV dz in pt with known vascular disease (CAD, PVD, CVA) or diabetes and one additional risk factor
Heart protection study
- statins
- in patients at high risk of coronary event, simvastatin reduces risk of death, MI, CVA irrespective of cholesterol levels
Courage trial
*PCI in stable CAD does NOT reduce risk of death, MI or other major CV event even when added to optimal medical therapy
complications of PCI
- mortality 0.1-0.3%
- periprocedural MI 5-30%
- stent thrombosis
- restenosis
- bleeding
recurrent CP with ST elevation lasting 20-30 minutes. no exertional CP
- prinzmetal angina
- no beta blockers
- tx: acute: sublingual NTG, long term tx: nitrate or calcium channel blocker
a patient w anterior wall MI, EF 30%, LDL 140, what medications the pt should be discharged on?
ASA B blocker statin ACE plavix x 1 year
elderly pt admitted w syncope and normal EKG on admission. after meals he feels dizzy and EKG shows ST elevation in II, III, AVF that lasts for 20 minutes. what does this indicate?
needs angiography
on 6th day after MI, patient lapses into coma, no pulse but EKG shows RSR
*cardiac rupture and pt in PEA
inferior wall MI + RBBB, what artery is involved?
right coronary
severe dyspnea on day 5 after MI with decreased BP, increased JVP, ECHO shows RV collapse in diastole. what is problem
- cardiac tamponade
- pericardialcentesis
- stop anticoagulants
acute STEMI with SOA, BP 100/70, incr JVP,, crackles midway up both lungs. what drug is contraindicated?
- beta blocker
* pt in frank heart failure with acute MI-NO BB’s given in this case
low back pain after cardiac cath with drop in HCT indicates
retroperitoneal hematoma
stable angina, 75% stenosis of circumflex, LDL 140. how should this patient be treated?
medical therapy
what to do if patient develops recurrent angina 2 weeks after acute MI?
cardiac cath
what is the initial treatment of a pt w second degree Mobitz II heart block after acute inferior MI?
atropine IV to increase vagal tone
how to treat a patient who develops broad complex regular tachycardia at rate of 100 after fibrinolytic therapy
observe
how to treat frequent PVCs within 24 hours after MI?
no tx
how to treat sustained VT or VF WITHIN 48 hours after MI?
amiodarone or procainamide if stable, if unstable cardiovert of defibrillate
how to treat sustained VT or VF 48 hour AFTER MI?
EP studies and ICD insertion
after an acute anterior MI, pt has SBP 70, confusion, poor urine output. right heart cath shows PCW of 22, cardiac index 1.4. how to treat?
pt in cardiogenic shock
*tx PCI or CABG so needs to go to cath lab to determine
how to evaluate exertional CP in pt with coronary stent?
exercise nuclear stress test
what are the neurological complications after CABG?
neurocognitive dysfunction
treatment of AF that is assoc w hemodynamic instability, pulmonary edema, unstable angina
urgent cardioversion
tx of AF in pt that is stable
- slow heart rate w beta blocker, calcium channel blocker (diltiazem or verapamil), digoxin or combo
- if AF persists-rate control and warfarin
- if persists and need rhythm control, 48 hr need heparin & TEE before cardioversion
management of AF
- rate control and chronic anticoagulation is recommended strategy for most patients, rhythm control is not superior to rate control.
- all need long term anticoag w warfarin unless contraindication
- 2 strategies to cardioversion
- short term antigoag w heparin and cardioversion if TEE w no thrombus
- 3 weeks of warfarin then cardioversion
- if convert to sinus, rhythm maint meds not used in most
CHADS2 scoring
CHF (any hx of it) or EF<35% 1 point HTN (prior hx) 1 point age 75 or older 1 point diabetes 1 point prior CVA,TIA, systemic embolic event 2 points
CHADS2 scoring and tx for AF
score 0: no rx or ASA
score 1: ASA or anticoagulant tx
score 2 or more: anticoagulant tx
anticoagulant therapy for AF
- warfarin INR 2-3
- pradaxa (dabigatran) direct thrombin inhibitor, 150mg BID
- xarelto (rivaroxaban) factor Xa inhibitor, 20mg daily
- eliquis (apixaban) factor Xa inhibitor 5mg BID
surgery in AF pt on warfarin
*LOW risk: CHADS2 score 0-2, interruption
- HIGH risk: CHADS2 score 5-6, recent CVA/TIA, mech.mitral valve or rheumatic valve dz
- stop warfarin 5 days before procedure
- brige w LMWH or other starting 3 days before procedure
- resume LMWH 24hr p minor surg, 488-72hr major surg
- warfarin restart 122-24hr after surgery
AVNRT-AV nodal reentrant tachycardia
*antegrade conduction by slow pathway and retrograde conduction by fast pathway
- TX:
- vagal
- adenosine, if no response-verapamil
- maintenance-BB,digoxin, verapamil, flecainide, propafenone
- recurrent-radiofreq. ablation
atrial tachycardia
- originates site in atria other than the SA node
- rate 140-250
*causes: dig toxic, pulmonary dz, prior cardiac surgery
*Tx: slow rate w BB, diltiazem or verapamil
attempt conversion w procainamide, or amiodarone
recur-cardioversion or catheter ablation
atrial flutter
*HR 250-350, vent.rate usually 150
*tx:same as a fib
WPW syndrome
*short PR interval, wide QRS complex, delta waves
- indications for EP study and catheter ablation
- AF, A flutter or SVT
- unexplained syncope
- recur palpitations
- No tx for asymptomatic WPW
Wide complex tachycardia
**DO NOT use verapamil
TX: -IV amiodarone or procainamide -cardioversion if hemodynamic compromise -pulseless-defib ICD for hemodynam. impt sustained VT and structural heart dz
Torsades de Pointes-causes (QT prolongation)
- antiarrhythmic drugs
- metabolic: hypokalemia, hypomagnesemia, hypocalcemia, hypothyroidism
- psychotropic drugs
- antihistamines
- antibiotics
- congenital QT prolongation
- starvation, anorexia, liquid protein diet, cisapride
Tx torsades de pointes
- IV magnesium even if Mg is normal
- stop offending drugs
- over drive pacing
- lidocaine or bretylium can be used
antiarrhythmic drugs
- IA-quinidine, procainamide, disopyramide
- IB-lidocaine, tocainide, mexilene
- IC-flecanide, propafenone
- II-beta blockers
*III-amiodarone, dronedarone, bretylium, sotalol, ibutilide, dofetilide
*IV-verapamil, diltiazem
Other-digoxin, adenosine
toxicity of antiarrhythmic drugs
all can cause proarrhythmic effect EXCEPT: BB & CCB
toxicity of quinidine
thrombocytopenia
potential toxicity of procainamide
SLE
potential toxicities of amiodarone
- pulmonary fibrosis
- NASH
- hypo or hyperthyroidism
- increase warfarin action
- increase digoxin levels
potential digoxin toxicity
- hyperkalemia
- hypotension
- renal failure
- altered mental status
Indications for permanent pacemakers
- alternating BBB
- symptomatic complete or 2nd degree AV block-Mobitz 1 or 2
- asymptomatic complete heart block with HR<40
- sinus pauses
- symptomatic bifascicular block
- neurocardiogenic syncope w >3 second pauses induced by minimal carotid sinus pressure
- AF w pauses >5 seconds
causes of syncope
- neurally mediated-vasovagal
- orthostatic-drug induced
- autonomic nerv. system-diabetes, parkinsons
- cardiac syncope
causes of cardiac syncope (6mo mortality >10%)
- CAD
- cardiomyopathy
- valvular heart disease
- tachy or bradyarrhythmias
- genetic (family hx syncope or sudden death)
- familial dilated cardiomyopathy, WPW, QT syndromes
- arrhythmogenic RV cardiomyopathy
- brugada syndrome
- catecholalaminergic polymorphic VT
diagnosis of cardiac syncope
- implantable loop recorder-greatest diagnostic yield and cost effectiveness
- EKG,ECHO,stress test, tilt table, event and holter monitors
Long QT syndrome
- QTC >460ms males, >440ms female
- incr risk torsades
- syncope and sudden death can occur
- emotional & physical stress or loud noise can trigger sync/death
TX
- Beta blocker, if ineffective> BB + ICD w dual chamber pacing
- no participation in athletic activities
- ICD for recurrent syncope, cardiac arrest or sustained VT
Brugada Syndrome
*EKG: incomplete RBBB, coved ST elevation lead V1 to V3
these patterns can be intermittent and makes dx difficult
- hx of syncope increases risk of sudden death due to polymorphic VT
- ICD placement for recurrent syncope
Radiofrequency ablation is indicated for
- recurrent SVT-all types
- WPW syndrome
- atrial flutter-type I (II,III, aVF)
- control of vent rate in A fib
- idiopathic ventricular tachycardia
First degree heart block
- PR interval >0.20s
* may be normal or caused by drugs: BB, diltiazem verapamil, digoxin
Second degree Mobitz I - Wenckebach
- progressive increase in PR interval followed by a drop beat
- narrow QRS
no tx needed
Second degree Mobitz II
- fixed PR interval with drop beats in 2:1, 3:1, 4:1 fashion
- QRS usually wide
- may progress suddenly to complete AV block
* needs pacemaker
Third degree heart block - complete AV block
- no conduction from atrium to ventricle
- no relation of p wave to QRS
- usually wide QRS
- vent rate 30-50
* pacemaker needed
CHF - due to systolic dysfunction
- dyspnea, edema
- increased BNP
- decreased EF
- ECHO-dilated ventricles, incr LA size, decr contractility
CHF-due to diastolic dysfunction
- dyspnea, edema, BNP increased
- EF normal >50%
ECHO: normal contractility, increased LA size, ventricle size normal
treatment of systolic dysfunction CHF
- ACE inhibitors, ARBs
- diuretics-loop, may need add thiazide, spironolactone in tol.
- digoxin-decreases hopitalizations
- B blockers-coreg, metoprolol,bisoprolol
- vasodilators-hydralazine, isosorbide
- biventricular pacing, ICD
treatment of diastolic dysfunction CHF
- diuretics
- ACE,ARBs
- BB
- nondihydropyridine calcium blockers
CHF in blacks
*Isosorbide + hydralazine added to standard tx in blacks with stage III&IV heart failure reduces mortality
drugs to be AVOIDED IN CHF
NSAIDS
TZDs
diltiazem
verapamil
contraindication of beta blockers
- signs of clinically unstable heart failure
- asthma, COPD
- HR<100
- 2nd or 3rd degree heart block
BNP level and interpretation in CHF patient
*500 decompensated CHF
to do biventricular pacemaker in pt with heart failure must meet ALL of these criteria (also called cardiac resynchronization therapy)
- NYHA class III-IV symptoms while on optimal therapy
- QRS of 120 msec or greater
- EF 35% or less
-this device assoc w 50% reduction in mortality for progressive CHF
Implantable cardioverter-defibrillator (ICD)
- NYHA class II & III on optimal tx and expect to survive >1yr
- hx hemodynamically stable ventricular arrhythmia-syncope, near syncope, or cardiac arrest
- ischemic or non isch. cardiomyopathy with EF 35% or less
- EF 35% or less 40 days out from MI
ACC/AHA heart failure staging
A-at risk, no structural disease or symptoms
B-structural dz but no symptoms
C-structural dz w prior or current symptoms
D-refractory symptoms
NYHA functional classes
I-asymptomatic
II- slight limitation of physical activity
III-marked limitation of physical activity
IV-inability to perform any physical activity without symptoms
Hypertrophic cardiomyopathy
- marked LVH without a cause
- LV outflow obstruction> mitral regurgitation
- mutatin, autosomal dominant transmission
- s/s: dyspnea, angina, syncope, sudden death
*cardiac findings
-harsh midsystolic murmur, incr w stand/valsalva
-S4,brisk carotid upstroke, blowing murmur at apex (MR)
EKG:LVH, Qwaves in leads I, aVL, V5-V6
treatment of hypertrophic cardiomyopathy
- BB or nondihydro.CCB or disopyramide
- pt w outflow obstr or symptoms on pharm therapy
- dual chamber pacing, percutaneous septal ablation, surgical septal myectomy
*see above
Indications for ICD insertion in hypertrophic cardiomyopathy
*pt w hx cardiac arrest, sustained VT, hx sudden death in first-degree relative
- nonsustained VT on holter monitor
- abnl BP response to exercise
- syncope in young person, family hx of sudden death in 2 or more family members
- marked ventricular hypertrophy >30mm
things to avoid in hypertrophic cardiomyopathy
- competative sports, alcohol, hot tubs, sauna
- vasodilators-nitrates, dihydro CCB, hydralazine, ACE/ARBs, minoxidil, sildenafil
*positive inotropes:epi, norepi, isoproterenol, dopamine, dobutamine, digoxin
follow up on pt with hypertrophic cardiomyopathy
- annual exercise stress test & holter monitor
* all first degress relatives should be screened by ECHO every 5 years
signs of severe aortic stenosis
+S4
paradoxical splitting of 2nd heart souns
late peaking of murmur
ECHO findings of aortic stenois
Moderate AS: mean gradient 25-40, valve area 1-1.5cm2
Severe AS: mean grad >40, valve area <1cm2